HCA: Material agreement · New financial obligation · Other company developments

Item 1.01 Entry into a Material Definitive Agreement. Issuance of $6,500,000,000 aggregate principal amount of senior notes Overview On November 5, 2026, HCA Inc. (the “ Issuer ”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “ Parent Guarantor ”), completed the public offering of (i) $500,000,000 aggregate principal amount of its 5.200% Senior Notes due 2028 (the “ 2028 Notes ”), (ii) $300,000,000 aggregate principal amount of its Floating Rate Senior Notes due 2028 (the “ Floating Rate Notes ”), (iii) $1,000,000,000 aggregate principal amount of its 5.350% Senior Notes due 2029 (the “ 2029 Notes ”), (iv) $1,250,000,000 aggregate principal amount of its 5.500% Senior Notes due 2031 (the “ 2031 Notes ”), (v) $1,200,000,000 aggregate principal amount of its 5.750% Senior Notes due 2033 (the “ 2033 Notes ”), (vi) $1,500,000,000 aggregate principal amount of its 6.000% Senior Notes due 2036 (the “ 2036 Notes ”) and (vii) $750,000,000 aggregate principal amount of its 6.500% Senior Notes due 2056 (the “ 2056 Notes ” and, together with the 2028 Notes, the Floating Rate Notes, the 2029 Notes, the 2031 Notes, the 2033 Notes and the 2036 Notes, the “ Notes ”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “ Securities Act ”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “ Registration Statement ”), as supplemented by the prospectus supplement dated November 2, 2026, previously filed with the Securities and Exchange Commission under the Securities Act. On November 5, 2026, the Notes were issued pursuant to an indenture dated as of August 1, 2011 (the “ Base Ind